CHARLES RIVER LABORATORIES INTERNATIONAL INC

128.81 +1.11 (+0.86%) Buy

Joy for CRL investors as it was among the best performers

13 min read

CHARLES RIVER LABORATORIES INTERNATIONAL INC ranked among the best performers on Tuesday. It delivered +0.86% to close at 128.81. On a day when the overall market breadth was 35%, it closed higher than 5% of the market. In comparison, the benchmark SP500 index closed today at -0.0004%.

[Themes containing CRL]

CRL is currently in a bullish trend. Over the last three months Buy-and-Hold has been a better strategy (returning -1.63%) for CRL's investors than trading long signals.

Trend

CRL has been outperforming the SP500 index in recent time. It showed significant outperformance (compared to the SP500 index) from 1 Dec, 2016 to 3 Dec, 2018. Over the last 2 years 11 months and 7 days, CRL outperformed the SP500 index on 54% days.

During the last three months CRL was mostly profitable and delivered on average -0.0% per day. It's best return during this period (of +8.86%) was on Wednesday, 7 Nov, 2018. While it's worst loss in the same period (of -6.83%) was on Wednesday, 24 Oct, 2018. The longest stort-term trend during this period was 7 profitable days, which started on 30 Oct, 2018 and went on till 7 Nov, 2018. This bullish trend returned +15.11% to investors.

The last 12 months saw CRL's investors making profits in 8 months and incurring losses in 4 months. During the last year, CRL and SP500 index had the same number of profitable months. CRL significantly outperformed SP500 index in Jul 2018, when it returned +10.87% compared to +4.75% returned by SP500 index during it's best month in the last one year - Jan 2018. CRL and SP500 index, both had periods of 6 consecutive profitable months.

A real entrepreneur is somebody who has no safety net underneath them.
-- Henry Kravis

CRL is currently seeing overall fall in volatility. In comparison, the SP500 index is seeing increase in volatility. During the last three months, there was a significant surge in CRL's volatility from 3 Oct, 2018 to 7 Nov, 2018. While there was a significant surge in the SP500 index's volatility from 13 Sep, 2018 to 29 Oct, 2018.

Advanced/professional short-term investors should note that CRL has significant positive skewness in it's return distribution. This indicates that investors can expect CRL to recover from drawdowns quickly. Which makes CRL a good candidate for investing on short-term bullish trends or even counter-trends hoping for a pull-back.

SP500 index has more chance of extreme outcomes than CRL. Therefore, SP500 must receive a lower allocation than CRL in your portfolio. SP500 index usually has shorter drawdown period than CRL.

On a general note (since you are interested in CRL), AAXN is a small cap that deserves to be closely tracked for investment opportunities.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Following
Symbol Price {{retType}} | Tr.
{{detail.symbol}} {{detail.close}} {{detail.priceChange}}  {{detail.pctChange}}%  {{detail.name}} {{detail.trend}} 
 
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter